Discover some of our success stories and insights.

GMOs are revolutionising healthcare by making it more sustainable and accessible. Genetic engineering, once the stuff of science fiction, is now part of everyday life, impacting fields like agriculture, research, and medicine. One of the most exciting advancements is the development of edible vaccines, offering immense potential for healthcare innovation. Discover how GMOs could drive major progress in our latest article exploring their transformative potential.

AI compliance is not a once-off task, but a continuous commitment that becomes more crucial as AI technologies become widespread. The growing complexity of ethical and regulatory challenges presents an opportunity for organisations to not only meet compliance standards but also to lead in promoting positive AI use. By proactively investing in AI literacy and increasing collaboration between technology and compliance experts, companies can help shape a more responsible and equitable AI-driven future. Now is the time to act, as the benefits of responsible AI adoption are significant. Read our article to find out more.

Laboratories consume three to ten times more energy per square foot than typical office buildings and four times more water, making them significant contributors to global resource use. Read our article to learn more about transforming labs to become more sustainable, including initial challenges and investments; changing mindsets; identifying changes that need to be made and encouraging behavioural changes.

While generative AI has gained widespread acceptance across most industries and businesses, the life sciences and healthcare sectors have yet to fully realise its benefits. The challenge mostly lies in the absence of a clear AI strategy, multiple stakeholders and regulatory requirements unique to the industry – adding another layer of complexity. Life sciences companies and healthcare providers are also hesitant to adopt this technology due to concerns regarding sensitive patient data. Read our article to find out more about how to overcome these challenges. We believe that life sciences and healthcare companies should start now, start lean, yet THINK BIG!  

A quarter of the 21st century has passed, yet the promise of affordable personalised precision medicine remains unfulfilled. Despite innovations, the life sciences industry is disconnected from real patient care. Our article explores how current R&D practices and entrenched biases hinder progress and highlights the urgent need for innovative solutions that align with the broader healthcare landscape. Discover why the future of medicine depends on reimagining our approach to therapeutic development.

At Arcondis, we have developed a deep understanding of the unique challenges faced by the Life Science industry, particularly in pharmaceuticals and MedTech. This understanding has led us to specialise in the field of qualification and validation, as we recognise its pivotal role in guaranteeing the safety and effectiveness of end-to-end processes throughout the entire product life cycle

To support your success with AI projects, we have established a maturity scale on which you can grade your organisation according to five operational Work areas and three support Drivers. Once you know where you stand, you can follow our recommendations and assessment to achieve results more rapidly, efficiently, and safely.

In this viewpoint, we outline a dynamic patient engagement by using various communication channels and the potential use of omnichannel engagement to integrate these channels. We conceptualize a novel patient care journey where multiple web-based and offline communication channels are integrated through a “digital twin.”

©Agata Blasiak, Yoann Sapanel, Dana Leitman, Wei Ying Ng, Raffaele De Nicola, V Vien Lee, Atanas Todorov, Dean Ho. Originally published in the Journal of Medical Internet Research (https://jmir.org), 16.11.2022.

This white paper focuses on how to drive digital engagement with a fine-tuned CIAM strategy that balance between customer experience and the security/compliance aspects, keeping in mind the special needs of the Pharma and MedTech industries.

The new European Regulations on Medical Devices (EU 2017/745) increasingly impact healthcare and contribute to an industry-wide uncertainty on compliance. Due to Switzerland’s bilateral agreements with the EU and the de-facto adoption of the EU regulations, there is a need for the Swiss healthcare industry to identify the best way to ensure compliance rapidly and efficiently with these regulations.

We prepared an overview of our Organisational Change Management Services from Arcondis. Here we cover the challenges and opportunities that come with OCM.

Read our pocket guide to find out more about R&D in the 21st century with Future Labs; Effective automation with Industry 4.0; Correctly handling risks with Quality Management; and Qualifying/validating design, processes & systems with CQV/CSV.

Embracing change has never been more relevant: each industry segment within Healthcare and Life Science is currently experiencing a seismic shift in their traditional ways of working, tools, and procedures. The digital transformation continues and incites change within every department.

With our unique focus on the Life Sciences and Healthcare sectors, we’ve stayed at the forefront of current trends and developments in these industries. Growing alongside our clients over the last two decades has given us a unique inside view and understanding of the specific challenges, needs and successful transformation approaches of key players

This paper is about the new FDA guideline on Computer Software Assurance (CSA), the differences to Computer System Validation, the benefits of CSA, and how Arcondis can support you with introducing CSA in your company.

Our experts give their views and insights on relevant topics, including: Industry 4.0; Annex 1; My Green Lab initiative; Computer System Validation (CSV); Quality Management and Future Lab.

Nowadays, there is almost no active medical device without some interaction with software. Since the introduction of the European Medical Device Regulation 2017/745 (MDR) and In-Vitro Diagnostic Medical Devices Regulation 2017/746 (IVDR), the industry talks about the impact and classification of Medical Device Software

We interviewed our OCM experts to find out how change has to be managed, what pitfalls can be avoided, and why change management improves long-term success.

We implemented an AI solution that pre-scans tissue samples, reducing the workload for scientists in research, improving analysis and reducing errors, and ultimately ensuring drug safety and efficacy for patients.

We developed a machine learning algorithm to create an automated redaction process which secures proprietary information while being compliant with new EU regulations.

We ensured that physicians have a much improved user experience with the manufacturers of the drugs they prescribe to the patient.

Through strong cooperation, we defined and improved low-maturity processes and workflows, making the manufacturing process faster and safer for patients.

Our dashboard solution enables physicians in hospitals to spend more time with patients instead of sifting through data.

Swiss healthcare business sustainability is at risk: by 2030, c.a. 30% of the Swiss population might struggle to pay their mandatory insurance premium.